| abstract |
New triazinic compounds of formula (I) wherein at least one of R, R1 and R2 which may be the same or different is a group (A) in which m is an integer of 1 to 6; p is an integer of 1 to 3; each of the R3 groups, which are the same in each single (A) group, is a free or esterified acid group; and the remaining of R, R1 and R2, if any, is a substituent selected from: a halogen atom, a hydroxy group or an amino acid, an ester thereof, a di-, tri-, tetra-, penta- or hexa-peptide or an ester thereof linked to the triazine ring through the amino group; and the pharmaceutically acceptable salts thereof, for use as angiogenesis inhibitors, TNFα-neutralizing activity agents and anti-lentivirus agents, are provided. |